Crown (CCK) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
4 Nov, 2025Executive summary
Second quarter performance exceeded expectations, with record segment income, adjusted EBITDA, and free cash flow, driven by strong Americas and European Beverage and North American food segments, and high plant utilization.
Net sales for Q2 2025 were $3,149 million, up from $3,040 million in Q2 2024, with net income attributable to shareholders at $181 million, up from $174 million; adjusted EPS was $2.15, up 19% year-over-year.
Six-month net income attributable to shareholders was $374 million, up from $241 million year-over-year.
The company remains focused on profitable growth, cash flow generation, and shareholder returns, with a $2 billion repurchase authorization through 2027.
Sustainability and ESG initiatives continue to be a strategic priority.
Financial highlights
Q2 net sales: $3,149 million (vs. $3,040 million in Q2 2024); six-month net sales: $6,036 million (vs. $5,824 million in 2024).
Q2 segment income rose to $476 million from $437 million year-over-year; six-month segment income up $129 million.
Free cash flow for the first six months was $387 million, up from $178 million; operating cash flow for the first half was $463 million.
Adjusted EBITDA for trailing twelve months: $2.1 billion, up 11% year-over-year.
Returned $269 million to shareholders in the first half, including $209 million in share repurchases.
Outlook and guidance
Full-year adjusted EPS guidance raised to $7.10–$7.50; Q3 adjusted EPS expected at $1.95–$2.05.
2025 full-year adjusted free cash flow projected at $900 million after $450 million in capex.
Net leverage ratio target reaffirmed at 2.5x by year-end.
Guidance assumes $360 million net interest expense, 25% tax rate, $310 million depreciation, and $160 million non-controlling interest.
No material direct impact from geopolitical conflicts in Russia/Ukraine or the Middle East is anticipated.
Latest events from Crown
- Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing23 Mar 2026 - Record EBITDA, strong cash flow, and improved leverage drive positive 2026 outlook.CCK
Q4 20255 Feb 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026 - Record EBITDA, strong cash flow, and reduced leverage highlight a positive 2025 outlook.CCK
Q4 20248 Jan 2026 - Q1 net income up to $193M, adjusted EPS up 64%, and guidance raised on strong can demand.CCK
Q1 20256 Jan 2026 - Board backs director elections, auditor, and pay, but opposes political spending disclosure proposal.CCK
Proxy Filing1 Dec 2025 - Q3 2025 delivered higher sales, strong European growth, and raised guidance with robust shareholder returns.CCK
Q3 202530 Oct 2025